Diabetic Peripheral Neuropathy (DPN) Completed Phase 2 Trials for Ketamine (DB01221)

Also known as: Peripheral Diabetic Neuropathy / Diabetic Peripheral Neuropathy / Diabetic Neuropathy Peripheral / Diabetic neuropathy / Diabetic Neuropathies

IndicationStatusPhase
DBCOND0049986 (Diabetic Peripheral Neuropathy (DPN))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00476151A Study of the Efficacy and Safety of Amitriptyline/Ketamine Topical Cream in Patients With Diabetic Peripheral NeuropathyTreatment